Standard Life or Lloyds would benefit from buying Aegon's UK arm, says US bank

JPMorgan says Standard Life could see a significant uplift to earnings if it acquires Aegon's UK arm, based on its assessment of potential buyers. The note implies a potentially accretive M&A outcome for Standard Life but is conditional on transaction execution and terms. Monitor any formal bids, deal structure and JPMorgan's quantified accretion estimates for near-term share impact.

Analysis

JPMorgan says Standard Life could see a significant uplift to earnings if it acquires Aegon's UK arm, based on its assessment of potential buyers. The note implies a potentially accretive M&A outcome for Standard Life but is conditional on transaction execution and terms. Monitor any formal bids, deal structure and JPMorgan's quantified accretion estimates for near-term share impact.